Voyageur Pharmaceuticals (CVE:VM) Shares Up 47.4% – Time to Buy?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) were up 47.4% during trading on Friday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares traded hands during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Trading Up 47.4 %

The stock has a market capitalization of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The stock’s fifty day moving average price is C$0.07 and its two-hundred day moving average price is C$0.06. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.